ATHENS — The COVID-19 crisis has put supply chain issues at the forefront of food production and packaging concerns. Researchers at the University of Georgia investigated a potential solution for
One housing provider is battling 100 COVID-19 cases, while at least 10 are hospitalized with bacterial infection.
Jen St. Denis is The Tyee’s Downtown Eastside reporter. Find her on Twitter @JenStDen. This reporting beat is made possible by the Local Journalism Initiative. SHARES Crowded sidewalks and housing and underlying health conditions have left Vancouver’s Downtown Eastside vulnerable to COVID-19 and other illnesses.
Photo by Jesse Winter.
The Downtown Eastside is dealing with two serious public health issues a rise in COVID-19 cases and an outbreak of shigellosis, a highly contagious bacterial infection caused by unsanitary conditions.
Announcements, Events & more from Tyee and select partners
and last updated 2021-03-02 14:06:07-05
OMAHA, Neb. (KMTV) â The Alzheimerâs Association released data Tuesday providing a deeper look into the impact of the disease on Nebraskans.
New statistics revealed the following, according to the Alzheimerâs Association:
Number of Nebraska residents aged 65 and older living with Alzheimerâs: 35,000
Estimated number of Nebraska residents living with Alzheimerâs in 2025: 40,000
Percentage change: 14.3% Number of Iowa and Nebraska residents serving as unpaid family caregivers: 61,000
Total hours of unpaid care provided: 51 million Total value of unpaid care: $894 million
The report shows Alzheimerâs and other dementias continue to significantly burden many Nebraska families. The COVID-19 pandemic was also examined in the report, adding that there were at least 42,000 more deaths from Alzheimerâs and related diseases total in 2020 compared with averages over the previous five years, marking a 16% incre
02 marzo 2021 17:14
Fonte: Adnkronos
#salute-e-benessere
AUSTIN, Texas, March 2, 2021 /PRNewswire/ Beyond Batten Disease Foundation (BBDF) is pleased to announce an agreement with Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, to provide Zavesca® (miglustat) for the development of BBDF-101, a proprietary combination of miglustat and trehalose to treat juvenile Batten disease (CLN3). Janssen will provide drug supply for the clinical trials and Extended Access Program, and right of reference to data within the Zavesca New Drug Application (NDA) to support the development of BBDF-101.
CLN3, one of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), is a rare, fatal, inherited, neurodegenerative disease for which there is no treatment. Since it was founded in 2008, BBDF has spearheaded the development of BBDF-101.
A new study has revealed that the Pfizer-BioNtech COVID-19 vaccine might be less effective on obese people, media reports said.The study carried out by a group of Italian researchers, suggested that o